Article Versions Notes

Schiuma M, Dinegro S, Battini V, Torre A, Covizzi A, Civati A, Galimberti M, Mariani I, Mosini G, Carnovale C, et al. NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort. International Journal of Molecular Sciences. 2025; 26(8):3881. https://doi.org/10.3390/ijms26083881

Schiuma, Marco, Sofia Dinegro, Vera Battini, Alessandro Torre, Alice Covizzi, Aurora Civati, Miriam Galimberti, Ilaria Mariani, Giulia Mosini, Carla Carnovale, and et al. 2025. "NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort" International Journal of Molecular Sciences 26, no. 8: 3881. https://doi.org/10.3390/ijms26083881

Schiuma, M., Dinegro, S., Battini, V., Torre, A., Covizzi, A., Civati, A., Galimberti, M., Mariani, I., Mosini, G., Carnovale, C., Riva, A., Gori, A., Antinori, S., Clementi, E., Radice, S., & Cheli, S. (2025). NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort. International Journal of Molecular Sciences, 26(8), 3881. https://doi.org/10.3390/ijms26083881